Grants and Contributions

Project activities include: (1) distributing emergency food assistance; (2) providing cash-based transfers to most vulnerable households; (3) treating moderate and acute malnutrition for children under five, including pregnant and lactating women; and (4) improving delivery of essential supplies, including for the cholera response.

Project activities include: (1) strengthening epidemiological surveillance; (2) supporting early and appropriate case management; (3) training health community workers; and (4) providing medical supplies and vaccinations as appropriate.

NRC provides contribution funding for the maintenance and operation of the BMC facility in a constant Good Manufacturing Practice (GMP)-readiness state to respond to pandemic and other health emergencies, ensuring surety of domestic vaccines and other biologics for Canadians.

This Project aims to reduce the incidence of COVID-19 related death and serious illness, particularly amongst priority groups and vulnerable populations, by increasing equitable access to and uptake of COVID-19 vaccines in five countries in the African region. The Project will support health systems strengthening to enable the delivery of gender-equitable COVID-19 vaccination and routine health services.

The tomato brown rugose fruit virus (ToBRFV) is an emerging disease threatening tomato industry by deteriorating fruit quality, reducing shelf life and making fruits unmarketable from 30% to 70%. ToBRFV can overcome all known genetic resistance genes resulting in all commercial tomato varieties being susceptible to the virus. Efforts to manage ToBRFV currently focus on using certified seed and maintaining strict biosecurity and sanitation practices. We have developed some attenuated ToBRFV strains that will be tested for the efficacy to protect tomato plants from the infection of wild-type ToBRFV in a commercial greenhouse.

The tomato brown rugose fruit virus (ToBRFV) is an emerging disease threatening tomato industry by deteriorating fruit quality, reducing shelf life and making fruits unmarketable from 30% to 70%. ToBRFV can overcome all known genetic resistance genes resulting in all commercial tomato varieties being susceptible to the virus. Efforts to manage ToBRFV currently focus on using certified seed and maintaining strict biosecurity and sanitation practices. We have developed some attenuated ToBRFV strains that will be tested for the efficacy to protect tomato plants from the infection of wild-type ToBRFV in a commercial greenhouse.

Examples of livelihood-based anticipatory actions for agriculture include: (1) rehabilitating water harvesting systems and reinforcing river banks; (2) distributing conditional or unconditional cash transfers, crop varieties, animal feed and supplements; (3) protecting livestock including vaccination, animal health campaigns and evacuation; and (4) diversifying livelihood.

Project activities include: (1) distributing food and cash-based transfer; (2) providing supplementary feeding for children under the age of five years and pregnant and lactating women; (3) providing logistical support and enabling access to the most remote and challenging locations.

Project activities include: (1) providing cash, vouchers, or in-kind food rations to address immediate food needs; (2) providing therapeutic and supplementary foods to boys, girls, and pregnant and lactating women; and (3) improving access to information to women and men from households experiencing acute food insecurity on sexual exploitation and abuse prevention.

To be eligible to the competition, applications must be co-led by Canadian and African researchers and address all objectives:

• Provide rapid evidence to inform clinical and health system management and public health response, and/or decision-making and planning within and across jurisdictions in Canada and internationally;
• Undertake robust, multi-country cross learning, and comparative research (including in collaboration with other international researchers where appropriate) on:
o the safety and real-world effectiveness of medical or other countermeasures deployed* (including vaccines and therapeutics) to treat and/or prevent monkeypox infections in people in Canada and globally; and
o the underlying serological histories and transmission dynamics of the current monkeypox outbreaks in Canada and globally (including time of exposure and transmission during asymptomatic phase, mechanisms of human-to-human transmission, and key risk factors for infection and transmission);
• Align with and contribute to the WHO Global Clinical Platform for monkeypox and other international monkeypox surveillance and research coordination activities by:
o adopting WHO case investigation and reporting forms;
o developing robust study protocols that can be integrated and harmonized with international clinical datasets; and
o contributing to global real-time sharing and analyses of research findings across different study contexts
*Please note that medical countermeasures against monkeypox (including vaccines, drugs and other therapeutic agents) will not be provided by the Government of Canada for research supported through this funding opportunity.